Category: News
-
Long‑Term Chlorpyrifos Exposure Raises Parkinson’s Risk – What Residents Near Farms Should Know
Researchers found that people who lived or worked near sustained chlorpyrifos use had over 2.5 times the risk of developing Parkinson’s disease compared with those with little or no exposure. Lab work in mice and zebrafish also showed movement problems, loss of dopamine neurons, brain inflammation, and buildup of alpha‑synuclein – the same hallmarks seen
-
A New Path to Stopping Epstein‑Barr Virus: How Scientists Created Human Antibodies That Block Infection
Epstein‑Barr virus (EBV) is one of the most common viruses on Earth, yet it rarely makes headlines. Most people catch it at some point in their lives, often without knowing it. But beneath its quiet reputation, EBV is linked to a surprising number of serious health problems – from infectious mononucleosis (“mono”) to certain cancers
-
Why Estrogen Patches Are Suddenly Hard to Find – And What Women Can Do About It
For many women navigating perimenopause or menopause, estrogen patches have become a lifeline. They’re small, discreet, and deliver a steady dose of hormone therapy that can ease hot flashes, night sweats, brain fog, and the general feeling that your body has suddenly changed the rules without warning. But over the past several months, women across
-
Common Food Preservatives Linked to Diabetes and Cancer
Food preservatives are everywhere. They help keep packaged foods fresh, prevent mold and bacteria, and extend shelf life. Without them, many grocery store staples wouldn’t last long enough to make it from factory to kitchen. But growing research suggests that some commonly used food preservatives may be linked to higher risks of serious health conditions,
-
FDA Expands Addyi Approval to Treat Postmenopausal Libido – What It Means and What to Know
Low sexual desire after menopause is common, and on December 15, 2025 the FDA expanded the label for Addyi (flibanserin) to include some postmenopausal women. This is a notable change: Addyi was first approved in 2015 for certain premenopausal women, and the new decision gives doctors another FDA‑cleared option for women under 65 who meet
-
Second Measles Surge of 2025: Why South Carolina’s Outbreak Is Accelerating and What You Need to Know
Measles is back in the headlines. After a major outbreak earlier this year, the United States is now seeing a second surge of measles cases, and one of the fastest-growing clusters is in South Carolina’s Upstate region. This post explains, in plain language, what’s happening, why it matters, and what you can do to protect
-
FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy — Itvisma (onasemnogene abeparvovec‑brve)
Background and mechanism Spinal muscular atrophy (SMA) is an autosomal‑recessive neurodegenerative disorder caused by loss‑of‑function mutations in the SMN1 gene, resulting in reduced survival motor neuron (SMN) protein, progressive motor neuron loss, and muscle atrophy. Gene‑replacement therapy using adeno‑associated virus (AAV) vectors delivers a functional copy of SMN1 to motor neurons, restoring SMN protein expression
-
CDC’s Shift on Vaccine and Autism Stance Nov 2025
Has the CDC Quietly Changed Its Stance on Vaccines and Autism? On November 19–20, 2025, the U.S. Centers for Disease Control and Prevention (CDC) made a significant and abrupt revision to its public-facing guidance on the relationship between vaccines and autism. This change, which replaced longstanding language unequivocally stating that vaccines do not cause autism
-
Can Viagra (Sildenafil) Reverse Damage in Genetic Deafness?
Hearing loss is a pervasive global health issue, affecting over 1.5 billion people worldwide, with sensorineural hearing loss (SNHL) accounting for the vast majority of cases. SNHL arises from damage to the delicate sensory hair cells or neurons within the cochlea, and until recently, such damage – especially when caused by genetic mutations – was
-
Marburg Virus in Ethiopia 2025: Outbreak Analysis, Challenges, and Global Preparedness
In November 2025, Ethiopia faced a historic and urgent public health challenge: its first confirmed outbreak of Marburg virus disease (MVD) in the southern Omo region, specifically in Jinka town. This event not only marked a significant milestone in the country’s epidemiological history but also raised pressing questions about regional preparedness, cross-border risks, and the